FREMONT, Calif., Oct. 27, 2016 -- Quantenna Communications, Inc. (NASDAQ:QTNA) today announced the pricing of its initial public offering of 6,700,000 shares of its common stock at a price to the public of $16.00 per share. In addition, Quantenna has granted the underwriters a 30-day option to purchase up to an additional 1,005,000 shares of common stock to cover over-allotments, if any. The shares are expected to begin trading on The NASDAQ Global Select Market on October 28, 2016 under the symbol “QTNA.”
Morgan Stanley & Co. LLC, Barclays Capital Inc. and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. Needham & Company, LLC, William Blair & Company, L.L.C. and Roth Capital Partners, LLC are acting as co-managers for the offering.
A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The offering is being made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-888-603-5847, or by email at [email protected]; or Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York NY 10005, by telephone at 1-800-503-4611, or by email at [email protected].
Investor Relations: The Blueshirt Group Suzanne Schmidt 415-217-4962 [email protected] Soohwan Kim, CFA 415-489-2208 [email protected] Media Contact: Lionel Bonnot 510-743-2260 [email protected]


Italy Fines Apple €98.6 Million Over App Store Dominance
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
FDA Approves Mitapivat for Anemia in Thalassemia Patients
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 



